Clinical trials
Mouth Neoplasms trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda USL 4 Prato | 1 |
| Catholic University of the Sacred Heart | 1 |
| Federico II University | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Sesen Bio, Inc. | 1 |
| Tobias Todsen | 1 |
| University of Bari | 1 |
| University of Milan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mouth Neoplasms | 12 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Head and Neck Neoplasms | 4 |
| Leukoplakia, Oral | 3 |
| Lichen Planus, Oral | 3 |
| Carcinoma, Squamous Cell | 2 |
| Laryngeal Neoplasms | 2 |
| Mouth Diseases | 2 |
| Oropharyngeal Neoplasms | 2 |
| Graft vs Host Disease | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.